Pifu-xingbing zhenliaoxue zazhi (Jan 2024)

Application of anakinra in inflammatory dermatoses

  • Xiaomei YOU,
  • Ganlin GU,
  • Yanyun JIANG,
  • Liangchun WANG

DOI
https://doi.org/10.3969/j.issn.1674-8468.2024.01.008
Journal volume & issue
Vol. 31, no. 1
pp. 41 – 47

Abstract

Read online

Interleukin 1(IL-1) is an important cytokine, which is involved in the development of many inflammatory diseases. IL-1 inhibitors have become an effective approach in the treatment of these diseases. Anakinra is the first and the most widely used IL-1 inhibitor on the market. Studies have shown satisfactory efficacy in the treatment of some inflammatory dermatoses. This review mainly summarizes applications of anakinra in adult-onset Still's disease, Schnitzler syndrome, hidradenitis suppurativa, pustular psoriasis, Bechet disease and pyoderma gangrenosum.

Keywords